Baker Bros. Advisors’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Hold	2,784,792	–	–	0.02%	79
2025 Q4	$2.78M	Hold	2,784,792	–	–	0.02%	79
2025 Q3	$5.07M	Hold	2,784,792	–	–	0.04%	73
2025 Q2	$4.04M	Hold	2,784,792	–	–	0.04%	70
2025 Q1	$3.84M	Hold	2,784,792	–	–	0.04%	64
2024 Q4	$8.47M	Hold	2,784,792	–	–	0.09%	56
2024 Q3	$13.9M	Hold	2,784,792	–	–	0.14%	47
2024 Q2	$16.3M	Hold	2,784,792	–	–	0.21%	43
2024 Q1	$22.1M	Hold	2,784,792	–	–	0.28%	40
2023 Q4	$16.2M	Hold	2,784,792	–	–	0.18%	40
2023 Q3	$7.13M	Hold	2,784,792	–	–	0.04%	57
2023 Q2	$6.96M	Hold	2,784,792	–	–	0.04%	67
2023 Q1	$5.85M	Hold	2,784,792	–	–	0.03%	69
2022 Q4	$4.32M	Hold	2,784,792	–	–	0.03%	81
2022 Q3	$8.49M	Hold	2,784,792	–	–	0.06%	65
2022 Q2	$8.76M	Buy	2,784,792 +1,359,792	+95%	+$3.72M	0.05%	65
2022 Q1	$3.99M	Hold	1,425,000	–	–	0.02%	92
2021 Q4	$6.41M	Hold	1,425,000	–	–	0.03%	89
2021 Q3	$11.9M	Buy	+1,425,000	New	+$13.2M	0.05%	74